Posted by Deborah Marshall

A Griffith University-led research team has discovered how a therapeutic target common among debilitating neurodegenerative disorders is activated, which could help accelerate drug development.

An international collaboration of researchers from Griffith University’s Menzies Health Institute Queensland, the University of Tartu, the University of Glasgow and the University of Dundee have developed a COVID-19 laboratory research toolkit for sharing with researchers across the globe. Designed to expedite SARS-CoV-2 vaccine development, drug discovery and fundamental research, particularly in laboratories unaccustomed to […]

Griffith University Institute for Glycomics researchers are closer to the development of a new vaccine aimed at preventing the deadly Streptococcus A (Strep A), which kills more than 500,000 people globally per year.

Rising to the challenge of a rapidly changing environment, Griffith University has developed new Graduate Certificates in Climate Change Adaptation and Renewable Energy Engineering.

Cancer, chronic kidney disease, diabetes and hypertension are the four main comorbidities leading to death from COVID-19, a Griffith University meta-analysis published in mBio has found. The researchers analysed global databases MEDLINE, Scopus, Web of Science and EMBASE of 375,859 participants from 14 countries and found chronic kidney disease was statistically the most prominent comorbidity […]

Do clocks run slower the closer they are to a nuclear reactor? Griffith University researchers are aiming to find out as they test a revolutionary new theory.

A new method of identifying molecular targets to fight disease could help accelerate future drug development new Griffith University research has found.